Theagene Jean-Manasse 4
4 · MAIA Biotechnology, Inc. · Filed Apr 8, 2025
Insider Transaction Report
Form 4
Theagene Jean-Manasse
Director
Transactions
- Award
Stock Options
2025-04-04+20,291→ 20,291 totalExercise: $1.50From: 2025-04-04Exp: 2035-04-04→ Common Stock (20,291 underlying)
Footnotes (1)
- [F1]The stock options, granted on April 4, 2025 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date.